Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
03/2007
03/14/2007CN1930171A 7H-8,9-dihydro-pyrano(2,3-C)imidazo(1,2A)pyridine derivatives and their use as gastric acid secretion inhibitors
03/14/2007CN1929833A Oxydecahydronaphthalene modulators of HM74
03/14/2007CN1927857A Extraction and purification process of buckwheat sprout total flavone
03/14/2007CN1304392C Method for synthesizing 3-(5'-substitution-2-benzoxazole group)-7-diethyl amino group H-1-benzopyrans-2-ketone
03/14/2007CN1304387C Separation and preparation of blushed rabdosia extract-A as check sample
03/13/2007US7189489 Oxime ester photoiniators having a combined structure
03/08/2007WO2007027959A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007WO2007025709A2 Organic compounds
03/08/2007WO2006137009A3 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents
03/08/2007US20070054909 VLA-4 inhibitor compounds
03/08/2007US20070054837 Bicyclic lactones, perfumery uses thereof, processes for preparing same and intermediates therefor
03/08/2007US20070054410 Dithio compounds
03/08/2007CA2620894A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers
03/08/2007CA2620222A1 Organic compounds
03/07/2007EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/07/2007EP1759696A1 Antineoplastic cocoa extracts, methods for making, using
03/07/2007EP1759694A2 Combinations of DMXAA and other anti-cancer agents
03/07/2007EP1758861A1 Dpp-iv inhibitors
03/07/2007EP1696902A4 Compositions containing d-tocopherol compound polybasic acid partial esters
03/07/2007EP1223808B1 Peripheral cannabinoid receptor (cb2) selective ligands
03/07/2007CN1926083A Manufacturing method of optical activity alcohol
03/07/2007CN1925862A Treatment of diseases associated with the EGR-1 enhancer element
03/07/2007CN1923831A Preparation technology of grape seed polyphenols
03/07/2007CN1923830A Preparation process of pine bark proanthocyanidin
03/07/2007CN1923829A Preparation method and use of separating and purifying lotus leaf flavone and lotus leaf alkaloid by employing polyamide
03/07/2007CN1923828A Preparation process of extracting bamboo leaf flavone series products in bamboo leaf
03/07/2007CN1303079C Process for the preparation of 3-isochromanone
03/07/2007CN1303078C Process for preparing effective constituent in tea
03/07/2007CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
03/06/2007US7186850 Synthesis of cannabinoids
03/06/2007US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors
03/06/2007US7186414 Improved bioavailability; for oral and intracolonic administration
03/06/2007CA2308806C Flavone analogues useful as antirejection agents
03/01/2007WO2007025129A2 Compositions and liquid crystals
03/01/2007WO2007002851A3 Thermally-processed cocoa products useful for vascular health improvement
03/01/2007WO2006104826A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/01/2007US20070049762 Process for the manufacture of trimethylydroquine dialkanoates
03/01/2007US20070049761 Substituted phosphonate fluorescent sensors and use thereof
03/01/2007US20070049605 5H-Dibenzo[c,g]chromene-3,9-diol; estrogen receptor modulators; osteoporosis
02/2007
02/28/2007EP1756080A1 Chromone derivatives useful as vanilloid antagonists
02/28/2007EP1756037A2 Amino alcohol derivatives and their activity as renin inhibitors
02/28/2007EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
02/28/2007EP1458703B1 Isochroman compounds for treatment of cns disorders
02/28/2007CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
02/28/2007CN1922135A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions
02/28/2007CN1919843A Preparation method of siliceous inorganic flavonoid molecular engram microsphere
02/28/2007CN1919219A Refining method of ginko total chromocor and method for preparing ginko damo injection
02/28/2007CN1301988C Method of extracting terpene lactone from folium ginkgo leaves and product
02/28/2007CN1301987C 7-carboxy-flavone derivatives, preparation method and therapeutic use
02/28/2007CN1301964C Inhibitors of alpha 4 mediated cell adhesion
02/27/2007US7183420 Reacting hydrogen peroxide with 1-hydroperoxy-oxabicyclo(4.10.0)hexadecane in presence of copper catalyst
02/27/2007US7183405 Labeling oligonucleotides comprising providing a solid support-bound oligonucleotide, an amino group comprised of bifunctional linker arm and an activated label, react support-bound oligonucleotide with bifunctional linker arm, react support with label, recover labeled, support-bound protected oligomer
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/27/2007US7183313 Keto cannabinoids with therapeutic indications
02/22/2007WO2007020917A1 Agent for enhancing and prolonging utrophin production and processed food comprising the same
02/22/2007WO2005123077A8 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
02/22/2007US20070043512 Therapeutic and prophylactic compositions and uses therefor
02/22/2007US20070043212 Crown ether derivatives
02/22/2007US20070042973 Treatment of pain and fever
02/21/2007EP1754702A1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity
02/21/2007EP1754614A1 Lithographic printing plate precursor and lithographic printing method
02/21/2007EP1754492A1 Novel drug discovery target and medicine acting on the same
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753838A1 Polymerisable naphthopyran derivatives and polymer materials obtained from said derivatives
02/21/2007EP1000025B1 Substituted naphthopyrans
02/21/2007CN1918140A Production of dihydronepetalactone by reduction of nepetalic acid
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1916016A Antiinflammation compound
02/21/2007CN1915987A Method for synthesizing Chinese baicalin, intermediate, and method for synthesizing intermediate
02/21/2007CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/21/2007CN1301256C Method for preparing inophyllolide C2 and application of preparing medication of anti SARS
02/21/2007CN1301252C Production method of high purity tea polyphenol and caffeine
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179906 Asymmetric benzoxanthene dyes
02/20/2007US7179838 Side effect reduction
02/20/2007US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis
02/15/2007WO2007018502A1 Stabilized 3-hydroxyflavan compositions and methods therefor
02/15/2007WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007WO2007002852A3 Heat-processed products having altered monomer profiles and processes for controlling the epimerization of (-)-epicatechin and (+)-catechin in the products
02/15/2007US20070037989 Reacting in the presence of an alkane- or arenesulfonic acid a (m-hydrocarboxyphenyl)(p-disubstitutedaminophenyl)amine and an o-benzoylbenzoic acid to form a fluoran dye, e.g., 2',3'-dimethyl-6'-[4-dimethylaminophenyl]amino-spiro[isobenzofuran-1(3H), 9'-[9H]xanthene]-3-one
02/15/2007US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
02/15/2007US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
02/15/2007US20070037877 trifluoro-methanesulfonic acid 3-(2,4-dimethoxy-phenyl)-4-(2-methoxy-ethyl)-2-oxo-2H-chromen-7-yl ester as potassium channel modulators; urinary incontinence, overactive bladder, hypertension, erectile dysfunction, female sexual disorders, dysmenorrhea, irritable bowl syndrome, airway hyperactivity
02/15/2007US20070037876 good insecticide activity against armyworm, diamond backmoth, aphids, carmine spider mite, two-spotted spider mite, lady beetles, mites and culex mosquitoes, especially for lady beetles and culex mosquitoes; wide spectrum fungicidal activity
02/15/2007US20070037874 Manufacturing process of isoflavan or isoflavene derivatives
02/15/2007US20070036860 Treatment of allergic conditions
02/15/2007CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/14/2007EP1751128A1 Chromene-derivatives with anti-tubulin and vascular targeting activity
02/14/2007EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
02/14/2007EP1750696A2 Resistance-repellent retroviral protease inhibitors
02/14/2007EP0999256B1 Compounds for organic el element and organic el element
02/14/2007EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds
02/14/2007CN1911925A 3,4-dihydro-III 2 benzopyran-1 ketone kind compound, its preparation method and use
02/14/2007CN1911924A Extraction method of Nepal eagle tail isoflavone, its derivative and medicipal composition using said derivative as active component
02/14/2007CN1911923A Method of extracting, separating soybean aglucone from kudzu
02/14/2007CN1911896A Process for producing chromone compound
02/14/2007CN1300147C Camptothecin derivatives preparing process
02/14/2007CN1300135C Method for preparing soybean isoflavone, soybean spanin, oligosaccharide and soybean concentrated protein
02/14/2007CN1300134C Baicalin preparing process
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 242